FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the…
Technology
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating delivery volume…
Unite to Fight the Flu – Influenza Season Update
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus, and the…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
FDA approves first quadrivalent vaccine to prevent seasonal influenza
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain four strains…
FDA announces agreement in principle on medical device user fees
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in principle on…
FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled because of…
U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)
On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of…
FDA approves expanded use of Prevnar vaccine
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and…
New minimally invasive technique treats acute DVT
Pharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps…
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating…
Unite to Fight the Flu – Influenza Season Update
There is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus,…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacements
On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…
FDA approves first quadrivalent vaccine to prevent seasonal influenza
On Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain…
FDA announces agreement in principle on medical device user fees
On Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in…
FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled…
U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)
On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate…
FDA approves expanded use of Prevnar vaccine
The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50…
New minimally invasive technique treats acute DVT
Pharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.